Inflammatory disorders

Nearly 5 million asthmatics could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.

Medications

New drug for vaginal yeast infections approved by FDA

(HealthDay)—A new and expensive antifungal drug to treat vaginal yeast infections was approved by the U.S. Food and Drug Administration this week, but critics say it is not needed.

Diseases, Conditions, Syndromes

Combo therapy helps knock out fungal meningitis

(HealthDay)— A drug regimen containing two powerful antifungal medicines—amphotericin B and flucytosine—reduced the risk of dying from cryptococcal meningitis by 40 percent compared to treatment with amphotericin B ...

Diseases, Conditions, Syndromes

Better tests needed to identify Candida auris susceptibility

Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision. That decision relies on susceptibility testing, but commercially available antifungal tests perform ...

page 3 from 6